HMA Related Analyst Ratings
-
IPPS Rule Proposal a Positive for Hospital Stocks - Jefferies (CYH) (HMA) (HCA) (THC)
-
Deutsche Bank Cuts Community Health (CYH), Health Management (HMA) and Tenet (THC) to Hold
-
Jefferies Upgrades Health Management (HMA) to Buy, Sees Meaningful Upside
-
Morgan Stanley Starts Health Management (HMA) at Underweight
-
Raymond James Downgrades Health Management (HMA) to Market Perform
-
JPMorgan Starts Health Management (HMA) at Neutral
-
Imperial Capital Upgrades Health Management (HMA) to Outperform
-
Notable Analyst Rating Changes 12/03: (DELL) (ITUB) (IGT) Upgraded; (RIMM) (QLGC) (BSBR) Downgraded
-
CRT Capital Downgrades Health Management (HMA) to Sell following "60 Minutes"
-
Baird Downgrades Health Management (HMA) to Neutral
-
Avondale Partners Starts Health Management (HMA) at Market Outperform
-
Barclays Starts Health Management (HMA) at Equalweight
-
Imperial Capital Starts Health Management (HMA) at In-Line
-
WallachBeth Capital Downgrades Health Management (HMA) to Hold
-
WallachBeth Capital Starts Health Management (HMA) at Buy
-
Jefferies Downgrades Health Management (HMA) to Hold; Sidelined with Wait-And-See Approach
-
UBS Maintains a 'Sell' on athenahealth (ATHN); Decent Quarter, But Valuation Too High
-
Susquehanna Downgrades Health Management (HMA) to Neutral
-
Raymond James Downgrades Health Management (HMA) to Outperform
-
Canaccord Genuity Morning Coffee on SPDR Health Care E.T.F. (XLV): Good News, Bad News
-
UPDATE - UBS Initiates Coverage on HMA (HMA) with a Buy; Initiatives Will Continue to Run
-
UBS Starts CYH, HMA, HCA at Buy, THC, CCRN, VHS, UHS, LPNT at Neutral
-
Citi Upgrades Healthcare Stocks Ahead of Supreme Court Decision on Reform (THC) (HMA) (CYH) (HCA) (UHS) (VHS) (LPNT)
-
Auriga on Healthcare Services: MAKO Misses 1Q12 Expectations; Read-through for HMA
-
Auriga Maintains a 'Buy' on Health Management (HMA); Q1 Beats with Higher Revenues
-
Jefferies Reiterates a 'Buy' on Health Management (HMA); Adjusting Estimates and PT After Q1 Results
-
Barclays Maintains an 'Overweight' on Health Management (HMA); Takeaways From Barclays Global Health Care Conference
-
Auriga Reiterates a 'Buy' on Health Management (HMA); Flu Activity Down, Orthopedic Surgeries Up
-
Cantor Fitzgerald Starts Health Management (HMA) at Hold; Good Strategy, But Waiting For Recovery
-
Deutsche Bank Upgrades Health Management (HMA) to Buy; Recent Sell-Off = Opportunity
-
Analyst Says Buy the Dip in Health Management (HMA) Shares; General Counsel Resignation Not Related to Litigation
-
Health Management (HMA) Shares Rebound as Susquehanna Defends, Says Buy the Dip
-
Citi Downgrades Health Management (HMA) to Neutral
-
Barclays on U.S. Autos & Auto Parts: Used Car Pricing Remains Flat
-
Barclays on Health Care Facilities: Headline Risk Around Florida Medicaid Is Not a Surprise
-
Raymond James Upgrades Health Management (HMA) to Strong Buy
-
Leerink Swann Upgrades Health Management (HMA) to Outperform; Prepayment Audit Fears Overblown
-
Barclays on Medical Supplies & Devices: 3Q11 Review; Preliminary 2012 Outlook
-
BMO Capital Starts Health Management (HMA) at Market Perform
-
Barclays Maintains an 'Overweight' on Health Management (HMA); Sept Qtr Review
-
Barclays Maintains an 'Overweight' on Health Management Assoc (HMA); Raising FY Estimates
-
Jefferies Maintains a 'Buy' on Health Management (HMA); Good Q3 Fuels Optimism For Now
-
Deutsche Bank Downgrades Lifepoint Holdings (LPNT) to Hold; Headwinds Appear Too Strong
-
Deutsche Bank Downgrades Health Management (HMA) to Hold; Headwinds Appear Too Strong
-
Oppenheimer Upgrades Health Management (HMA) to Outperform
-
Argus Downgrades Health Management (HMA) to Hold
-
CRT Capital Downgrades Health Management (HMA) to Fairly Valued
-
Jefferies Cuts Price Target on Health Management (HMA), Debt Ceiling Remains Biggest Near-Term Concern
-
UPDATE - Auriga Initiates Coverage on Health Management Associates (HMA) with a Buy; The DaVinci Code; “Mako-ing” Growth
-
Auriga Starts Health Management (HMA) at Buy
Back to HMA Stock Lookup
